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All rightsAbstract. This review analyzes the currently available literature on circadian rhythms of intraocular
pressure (IOP), blood pressure, and calculated ocular perfusion pressure (OPP) in patients with open-
angle glaucoma. Although adequately powered, prospective trials are not available. The existing
evidence suggests that high 24-hour IOP and OPP fluctuations can have detrimental effects in eyes with
glaucoma. The currently emerging continuous IOP monitoring technologies may soon offer important
contributions to the study of IOP rhythms. Once telemetric technologies become validated and widely
available for clinical use, they may provide an important tool towards a better understanding of long-
and short-term IOP fluctuations during a patient’s daily routine. Important issues that need to be
investigated further include the identification of appropriate surrogate measures of IOP and OPP
fluctuation for patients unable to undergo 24-hour measurements, the determination of formulae that
best describe the relationship between systemic blood pressure and IOP with OPP, and the exact
clinical relevance of IOP and OPP fluctuation in individual patients. Despite the unanswered
questions, a significant body of literature suggests that OPP assessment may be clinically relevant in
a significant number of glaucoma patients. (Surv Ophthalmol 58:26--41, 2013.  2013 Elsevier Inc.
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perfusion pressureI. Physiological Considerations
The principal physiological entities that affect
intraocular pressure (IOP) and its characteristics
are the aqueous humor (AH) dynamics in healthy
and glaucomatous eyes.
The production of AH involves two consecutive
processes. First, a portion of the plasma that reaches
the vascular plexus of the ciliary processes is filtered
through the fenestrated capillaries into the in-
terstitial space between the vessels and the ciliary
epithelia. Next, a portion of the filtrate is actively26
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reserved.secreted by the ciliary epithelial cells into the
posterior chamber.
In humans, these processes are affected by age,
circadian rhythm, topical and systemic medications,
and the presence of glaucoma.63,64,70,109,121 The rate
of AH formation decreases with age: by 15--35%
between age 20 and 80 years.15,30 The rate of AH
production in humans is significantly lower at
night,99,119 attributed to decreased endogenous
circulating catecholamine levels, which may partly
explain the decreased nocturnal efficacy of topical0039-6257/$ - see front matter
http://dx.doi.org/10.1016/j.survophthal.2012.05.003
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AH flow are a-agonists and carbonic anhydrase
inhibitors. Although the efficacy of a-agonists to
suppress AH production is limited at night, carbonic
anhydrase inhibitors have similar efficacy through-
out the 24-hour cycle.68,69,119 Larsson et al found
that the diurnal rate of AH formation in untreated
open-angle glaucoma (OAG) patients was similar to
age-matched controls;55 glaucoma patients, how-
ever, had a higher rate of AH formation at night.
A. THE CONVENTIONAL PATHWAY
The bulk of aqueous humor in human eyes drains
through the conventional outflow pathway in a largely
pressure-dependent fashion. This pathway comprises
the inner uveal and the deeper corneoscleral parts of
the trabecular meshwork, the juxtacanalicular con-
nective tissue, the endothelial lining of Schlemm’s
canal, Schlemm’s canal itself, the collecting tubules
and aqueous veins, and the episcleral veins. The site of
increased resistance in eyes with glaucoma is thought
to be located at the juxtacanalicular connective tissue
and the endothelial lining of Schlemm’s canal as
a result of composition changes in extracellular
matrix components.14,26,32,33,42,72,74,114 Outflow facil-
ity in ocular hypertensive120 and OAG patients is
significantly lower than in age-matched controls.55
Recent results indicate that outflow facility is de-
creased at night in older healthy individuals.63
Additionally, studies in healthy and OAG patients
have shown that outflow facility decreases with
age,7,121 although this reduction in outflow is paral-
leled by an age-related reduction in aqueous
formation.15
B. THE UVEOSCLERAL (UNCONVENTIONAL)
PATHWAY
A significant proportion of aqueous in humans
drains through the uveoscleral or unconventional
pathway. This route is often referred to as pressure-
independent because, at least within the normal
IOP range, the uveoscleral flow does not depend on
the level of IOP to the same extent as trabecular
outflow.2 Based on indirect measurements and
estimations, this route constitutes 12--54% of total
outflow in healthy human eyes.2,121 There is no
conclusive evidence that flow through this pathway
is reduced in human eyes with glaucoma. Uveoscl-
eral outflow at night decreases as measured by
tonographic outflow facility,63 but these findings
were not reproduced when fluorophotometric out-
flow facility was used for the calculations.63 Uveoscl-
eral flow decreases with age,121 which is attributed to
the progressive increase of connective tissue in the
aging ciliary muscle.115 Several medications exertclinically relevant effects on this pathway. Prosta-
glandin derivatives induce an early, as well as
a delayed, ocular hypotensive effect by increasing
uveoscleral outflow. The former effect is thought to
result from relaxation of the ciliary muscle, which
augments the egress of aqueous through the ciliary
body,15 whereas the later is attributed to interstitial
tissue remodeling.73,124 Early reports11 and animal
experiments10 indicated that pilocarpine minimizes
uveoscleral flow by increasing the ciliary muscle
tone and thus obliterating intramuscular spaces;
these observations, however, have not been con-
firmed in human studies. For example, Toris et al
have shown that pilocarpine does not inhibit the
increase of uveoscleral outflow induced by latano-
prost.122 Although the interaction of pilocarpine
and prostaglandin derivatives can be complex,45
pilocarpine does not seem to adversely affect
uveoscleral flow in humans and can be combined
with prostaglandins.38
A retrospective analysis of data from fluoropho-
tometry studies34 described new associations be-
tween parameters of aqueous dynamics in healthy
eyes and those with ocular hypertension. In both
groups, a significant positive correlation was found
between aqueous inflow and trabecular meshwork
facility, suggesting a possible autoregulatory mech-
anism. On the other hand, a positive correlation was
found between aqueous inflow and uveoscleral
outflow in controls, but not ocular hypertensives.
Finally, in both groups, thicker corneas were
associated with lower aqueous production and lower
uveoscleral outflow. Neither the pathophysiologic
basis nor the clinical significance of these findings is
currently clear.II. Circadian Blood Pressure Variation
Blood pressure (BP) is one of the numerous
metabolic systems in humans that exhibit a circadian
rhythm (Fig. 1).82,104,113 For example, Millar-Craig
et al82 have shown that BP is lowest at around 3 AM
and increases gradually during the early morning
hours before waking, reaching a peak at mid-
morning. The BP rise that begins before waking
was not associated with physical activity. These
fluctuations have been attributed to the nocturnal
decrease of sympathetic activity and circulating
catecholamines. Importantly, cardiovascular events
such as myocardial ischemia and infarction or stroke
follow a circadian pattern that has been associated
with cardiovascular parameter changes.84
Based on the magnitude of the nocturnal BP
reduction, patients are often categorized as non-
dippers if the nocturnal decline is small or absent
Fig. 1. Circadian mean pattern of systolic and diastolic
blood pressure in 34 combined dipper and non-dipper
patients. Modified from Staessen et al.107
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over-dippers if their pressure falls excessively
(O20%). This classification was adopted following
observations that hypertensive patients who did not
exhibit a nocturnal BP drop (non-dippers) had
a higher risk of vascular damage than the majority of
patients with a dipping pattern.27,105,123 Compared
with dippers, both non-dippers and over-dippers
may have a suboptimal mechanism of circadian BP
regulation, which is associated with a higher risk of
vascular end-organ damage.27,28,123 Based on these
findings, there is a potential relationship between
glaucoma and nocturnal variations in BP.31,36,117
Tokanuga et al117 compared dippers with non-
physiologic dippers (non-dippers and over-dippers)
and found that non-physiologic dippers had a higher
incidence of visual field progression over a 4-year
period. Similarly, Graham and Drance31 showed that
patients with greater nocturnal BP dips were more
likely to have shown visual field progression despite
seemingly adequate IOP control.
Studies on circadian BP curves are usually
performed on inpatients. Twenty-four-hour BP
measurements performed in a hospital setting may
not accurately reflect a patient’s usual circadian
rhythm during routine daily life.91 Thus, findings
from institution-based BP measurements may need
to be interpreted with caution.III. Circadian Intraocular Pressure
Variation
Existing literature is divided on the importance of
IOP variability as an independent factor of glau-
coma development and progression. The term
‘‘fluctuation’’ loosely describes variation in IOPduring a given day, across days to months, or across
years. We use the following terminology:
 Diurnal fluctuation: Daytime IOP variation
measured during a particular day or 24-hour
cycle.
 Nocturnal fluctuation: Night-time IOP varia-
tion measured during a particular 24-hour
cycle.
 Circadian fluctuation: IOP variation measured
during a particular 24-hour cycle.
 Short-term fluctuation: Inter-visit IOP variation
measured across days to months.
 Long-term fluctuation: Inter-visit IOP variation
measured across months to years.
Corneal biomechanical properties may influence
circadian IOP measurements as evidence exists for
their phasic alteration throughout the 24-hour
cycle.46 The observed circadian variations in param-
eters such as central corneal thickness or hysteresis,
however, do not seem to account for the respective
IOP rhythms.
An inherent problem with circadian IOP investi-
gations is the assumption that awakening patients at
night for IOP measurements does not significantly
affect their endogenous IOP rhythm. To further
compound the problem, patients are often asked to
walk to a nearby slit-lamp and have their IOP
measured in the sitting position. A newly developed
24-hour telemetric contact lens--embedded IOP
sensor allows undisturbed tonometry of OAG
patients at home78 and corroborates some of the
existing evidence regarding the circadian IOP
pattern found in sleep laboratory studies.64,65,70A. EVIDENCE FOR THE ROLE OF SHORT-TERM
IOP VARIATION IN GLAUCOMA
The rationale for IOP measurements throughout
the 24-hour cycle is that IOP exhibits time-
dependent variation that can reach up to 6 mm
Hg over a 24-hour period in healthy eyes, even more
in eyes with glaucoma.24,25,54,71 Therefore, a single
office-hour IOP measurement offers little informa-
tion regarding the IOP profile of a particular
patient. This variation may be associated with optic
nerve injury because, at least in principle, the
continuous and excessive fluctuation of parameters
in any biological system may overwhelm the
homeostatic mechanisms responsible for buffering
stresses and thus cause tissue damage.
Different levels of evidence regarding the role of
IOP characteristics in glaucoma can be found in
several reports.8,9,23,35,85,88,98 Large, well-designed,
prospective studies on the importance of circadian
IOP fluctuation are currently lacking, and the
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results. For example, Asrani et al3 found a strong
association between diurnal fluctuations of IOP and
progression in 105 eyes of 64 treated OAG patients
using self-tonometry. Both the diurnal IOP and the
short-term fluctuation over multiple days were
significant predictors of progression. The mean
office IOP had no predictive value, and the mean
home IOP showed a weak association with pro-
gression. Others, however, have failed to find similar
associations.43 Consequently, the importance of 24-
hour IOP parameters in glaucoma remains an area
of controversy even among glaucoma experts.57B. CIRCADIAN IOP VARIATIONS IN UNTREATED
HEALTHY OR GLAUCOMATOUS EYES
The traditional view is that IOP is generally higher
in the morning, but recent research in both healthy
and glaucomatous eyes has questioned this. Liu
et al64 performed 24-hour IOP measurements with
a pneumotonometer every 2 hours in two groups of
young healthy volunteers in a sleep laboratory. In
the first group of 12 participants, IOP was measured
in the seated position during the day and the supine
position at night, whereas in the second group of 21
volunteers, IOP was determined in the supine
position only. For the first group, IOP measured in
the supine position at night was significantly higher
than in the seated position. This could be ex-
plained, at least in part, by the posture-related
increase of IOP usually attributed to the increase of
episcleral venous pressure.110 There was, however,
also a significant nocturnal IOP elevation in the
group measured only in the supine position (20.0 
0.4 vs 21.3  0.7 mm Hg, respectively; p ! 0.05).
This may indicate that a true circadian IOP rhythm,
aside from posture-related changes, is responsible
for the nocturnal IOP increase in these healthy
adults. The same investigators also examined the
IOP profile of 16 healthy volunteers who had
pneumotonometry measurements performed every
2 hours for 24 hours in both the sitting and supine
positions.65 The mean IOP was significantly higher
during the night both for the sitting and the supine
positions. Considering the fact that aqueous pro-
duction is decreased at night65 and that changes in
episcleral venous pressure cannot account for the
differences in sitting 24-hour IOP values, Liu et al
suggest that increased outflow resistance at night, an
as yet undescribed phenomenon, may be responsi-
ble for the increase of nocturnal IOP. Furthermore,
both the sitting and the supine 24-hour IOP curves
were synchronous, with no difference in the
magnitude of variation. Complementing previousfindings,67 these results indicate that the nocturnal
IOP elevation can also be detected in the sitting
position in healthy adults. In both reports, the
IOP troughs appeared at 9:30 PM, and the peaks at
5:30 AM.
These results on healthy volunteers are in contrast
with data from a number of institution-based studies
on untreated glaucoma patients. Konstas et al found
that although peak IOP in up to 45% of untreated
exfoliation glaucoma and 22.5% of untreated pri-
mary open-angle glaucoma (POAG) patients are
outside office hours,52 themean peak IOP in 24-hour
curves is generally between 6 AM and 10 AM.48,49,51
Quaranta et al found similar IOP profiles.92--94 These
discrepancies in the observed circadian IOP patterns
may be explained by differences in equipment
(pneumotonometer vs Perkins or Goldmann tonom-
eters) or study samples. Age differences in particular
need to be taken into account when comparing IOP
curves derived from different studies. Mansouri
et al79 found that older healthy individuals in a sleep
laboratory, irrespective of body posture, had a mean
cosine-fitted peak IOP at around 10:20 AM, whereas
the respective peak for younger healthy individuals
was earlier, between 5:30 AM and 6:30 AMdepending
on body posture. Additionally, sleep lab conditions
may create an environment that affects biological
rhythms. On the other hand, contrary to hospital-
based investigations, sleep laboratory studies may
allow for some adjustment to the patient’s usual
routine of food intake or activities in the sitting or
recumbent positions better simulating normal life.
For the majority of patients, 24-hour IOP phasing
is impossible. Therefore, the identification of
surrogate measures that may reflect nocturnal IOP
profiles is desirable. Mosaed et al, in a retrospective
chart review in a sleep laboratory, investigated the
relationship between nocturnal and office-hours
IOP.83 They analyzed 24-hour IOP data obtained
with pneumotonometry from 33 young healthy
participants, 35 older healthy participants, and 35
untreated, older glaucoma patients. Measurements
were taken every 2 hours in the sitting and supine
positions during the diurnal/wake period (7 AM to
11 PM) and in the supine position during the
nocturnal/sleep period. The mean supine office-
hours (9:30 AM to 3:30 PM) IOP had a strong
correlation with peak nocturnal IOP in older
glaucoma patients (r 5 0.713, p ! 0.001). The
correlation was weaker in older healthy participants
and absent in younger healthy participants. Similarly
for the sitting position, the mean office-hours IOP
had a strong correlation with peak nocturnal IOP in
older glaucoma patients, but the correlation was
weaker in older healthy participants and absent in
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sion, the authors developed two formulae:Fig. 2
positiPeak nocturnal IOP512:04þ 0:616
 average office-hour sitting IOP r250:361Peak nocturnal IOP55:98þ 0:771
 average office-hour supine IOP r250:508The investigators suggested that these formulae may
assist clinicians predict peak nocturnal IOP values,
based on office-hour supine or sitting measure-
ments in a significant proportion of older glaucoma
patients.
A recent prospective, multicenter study93 also
addressed the relationship between daytime sitting
IOP as a surrogate to nocturnal supine IOP in
untreated POAG patients (Fig. 2). The investigators
used Goldmann tonometry around the 24-hour cycle
and Perkins tonometry for nocturnal supinemeasure-
ments. The mean diurnal sitting readings (23.3  3.4
mmHg) were higher than themean nocturnal sitting
readings (21.5 4.0mmHg,p!0.001),but similar to
nocturnal supine readings (22.8  4.4 mm Hg, p 5
0.07). The peak daytime Goldmann readings, how-
ever, couldnot consistently predict thepeaknighttime
sitting or supine IOP, as only 70% of the participants
werewithin 1.0mmHgof thehighest daytime reading
for all nighttime supine and sitting values.
C. CIRCADIAN IOP VARIATIONS IN TREATED EYES
Jonas et al43 performed a retrospective chart
review of 855 eyes from 458 treated patients with
normal tension glaucoma (NTG), POAG, or ocular
hypertension. They investigated the potential asso-
ciation of 24-hour IOP parameters with disease. 24-hour IOP results for sitting and supine
on. Adapted from Quaranta et al.93progression after a mean follow-up of almost
56 months. In a multiple Cox proportional hazards
analysis, for the whole study population progression
was associated with age and neuroretinal rim area.
For the POAG group specifically, only age (p !
0.001) was a significant prognostic factor, whereas in
the NTG group, higher mean IOP (p 5 0.036) and
lower fluctuation (p 5 0.045) were identified as
predictors of disease progression. Participants were
receiving topical medication that is known to reduce
IOP levels and its fluctuation, and the effect of
24-hour IOP variation may have been blunted.
In a retrospective chart review of 29 treated POAG
and NTG patients, Hughes et al39 found that
although the mean office IOP determined in
previous visits was similar to the mean 24-hour
values, the peak IOP during 24-hour monitoring was
almost 5 mm Hg higher than the peak office IOP.
The mean circadian IOP variation amplitude was
9.4 mm Hg. More than half of the patients had peak
IOP values outside office hours, and in 14% of them
the peak circadian IOP was at least 12 mm Hg
higher than the office-hour peak. Importantly,
circadian IOP measurements led to clinical man-
agement modifications in almost 80% of patients,
with 45% of them being offered trabeculectomy.
The high proportion of patients whose management
was modified may reflect the fact that these patients
were offered a 24-hour monitoring because they
were deemed to be progressing despite apparently
adequate IOP control. The authors also compared
IOP values determined in an outpatient setting
using Goldmann tonometry versus values measured
during 24-hour phasing using Tono-pen, but argue
that the use of Tono-pen in circadian measurements
may in fact have underestimated IOP peaks and
fluctuation, because data suggest that the Tono-pen
may produce lower values than Goldmann at the
higher part of the IOP spectrum.4
In a similar study, Barkana et al6 reviewed the
records of 32 OAG patients who underwent Gold-
mann tonometry in the sitting position every two
hours from 7 AM until midnight and Perkins
tonometry in the supine position at 6 AM. They
compared office-hours and outside office-hours
values recorded on the same 24-hour IOP curve
for each patient, as well as IOP values determined in
up to five previous outpatient visits. All eyes were
treated or had undergone laser trabeculoplasty
and/or trabeculectomy. Although the authors re-
port that the mean 24-hour IOP was 13.0 mm Hg,
they do not report the mean office-hour (outpatient
or inpatient) IOP. The mean peak 24-hour IOP was
higher than the peak office IOP (16.8  3.2 vs
14.7  3.2 mm Hg, p ! 0.001) and the mean
24-hour fluctuation was higher than the office-hours
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0.001). The peak IOP in at least one eye was outside
of office hours in almost 70% of the patients. These
findings led them to immediate treatment modifi-
cation in 19 of 32 patients (59%), including laser
and incisional surgery. Similar to the study by
Hughes et al,39 these patients underwent 24-hour
phasing because of progression despite apparently
good office-hour IOP control. Therefore, the study
identified a higher-than-expected proportion of eyes
that needed treatment modification.
Nakakura et al87 also investigated the relation
between office and 24-hour IOP characteristics in 71
treated eyes of 42 POAG patients. Office IOP was
derived from three outpatient measurements (9 AM
to 6 PM) during a six-month period with the same
treatment. Circadian measurements were obtained
with a Goldmann tonometer in the sitting position
at 3-hour intervals. They found no significant
difference between mean office and mean 24-hour
IOP (16.2  4.6 vs 16.3  4.9 mm Hg, respectively),
but peak 24-hour IOP was recorded during office
hours in only one-third of eyes. Circadian IOP
fluctuation (peak minus trough 24-hour IOP) was
significantly greater than office-time fluctuation
(6.7  2.3 vs 2.7  1.7 mm Hg, respectively, p !
0.001), but there was no correlation between them.
In these treated patients, only 6 of 71 eyes (8.5%)
had a circadian curve with fluctuation less than
3 mm Hg, whereas 10 eyes (14.1%) had circadian
fluctuation greater than 10 mm Hg.
The effect of topical glaucoma medication on IOP
profile has been the subject of intense investigation
and debate. Prostaglandins administered either in
the morning or the evening have been shown to
have a similar IOP lowering efficacy throughout the
24-hour cycle.108,109 Similarly, topical carbonic anhy-
drase inhibitors seem to have comparable day- and
night-time efficacy.92,109 Most reports indicate that
b-blockers have a significant, albeit reduced, night-
time efficacy58,92,109 that may be explained by the
decreased nocturnal aqueous formation.99,119 These
findings were not confirmed in the sleep laboratory
studies by Liu et al, in which topical b-blockers had
a virtually non-existent nocturnal IOP-lowering
effect.67,68 Finally, brimonidine has been found by
most investigators to have a reduced nocturnal
efficacy.69,92,109
There is limited research on the effects of laser
treatment and filtration surgery on circadian IOP
rhythm.1,106 In a study by Lee et al,56 there was no
significant reduction inmean, peak, or rangeof office
hour IOP or diurnal IOP after laser trabeculoplasty
on 28 treated eyes of 18 glaucomapatients; significant
nocturnal IOP reduction was observed, however.
Kothy et al53 performed selective lasertrabeculoplasty in 26 eyes of 13 patients after
appropriate washout and reported that no eyes
showed mean circadian IOP reduction of 20% or
more. Nonetheless, the treatment resulted in a signif-
icant decrease in the amplitude of circadian IOP
fluctuation.
Filtration surgerymay provide greater 24-hour IOP
control and smaller IOP fluctuation compared to
medical therapy. Medeiros et al81 studied 60 POAG
patients considered to be well-controlled who had
either undergone one or more trabeculectomies and
were untreated (n 5 30) or had never had filtering
surgery and were receiving a variety of topical
medications (n 5 30). They evaluated diurnal IOP
curves and the response to the water drinking
provocation test (WDT) for each group. The WDT
was used in the 1950s and 1960s as a diagnostic aid in
OAG and was later advocated as a tool to predict IOP
peaks during diurnal phasing, as well as to assess the
patency of filtering surgery.17,126 The authors found
that the diurnal IOP peak was higher and the IOP
fluctuation was greater in the medically treated
group. The same pattern in IOP peak and fluctuation
was seen after the WDT.
In a prospective observational study, Mansouri
et al77 examined the diurnal IOP curves of 20 POAG
patients considered well controlled (IOP ! 18 mm
Hg) with latanoprost monotherapy, 20 patients after
successful trabeculectomy with mitomycin C (un-
treated IOP ! 18 mm Hg), and 20 patients after
successful deep sclerectomy with collagen implant
(untreated IOP ! 18 mm Hg). The mean diurnal
IOP of the trabeculectomy-treated patients (10.1
mm Hg), was significantly lower than the mean
diurnal IOP of the other two groups (13.7 mm Hg
and 15.7 mm Hg for the deep sclerectomy and the
latanoprost-treated groups, respectively; p 5 0.1 for
the latanoprost vs deep sclerectomy groups). The
diurnal IOP fluctuation was comparable in the three
groups. They also examined the patients’ IOP
changes following the WDT. After the provocation,
the latanoprost-treated group had significantly
greater IOP elevation compared with the
trabeculectomy-treated patients (p 5 0.0002) and
marginally greater elevation compared to the deep
sclerectomy group (p 5 0.052).
In another prospective observational study, Kon-
stas et al50 compared 30 advanced OAG patients
successfully treated with trabeculectomy and 30
patients on maximal medical therapy considered to
be adequately treated. They found that the patients
with a successful trabeculectomy had lower mean
IOP, as well as lower peak and range of IOP over
24 hours, compared with patients on maximal
medical therapy. The 24-hour range of IOP was
2.3 0.8 mmHg for the surgical group and 4.8 2.3
MOP
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IOP peaks occurred outside of usual office hours.
Despite early recommendations about the clinical
usefulness of the WDT, this technique is not
performed in most centers because of a number of
concerns. First, its sensitivity and specificity may be
low when used as a diagnostic tool.97,101 Secondly,
the test was never standardized, so that the amount
and duration of fluid intake or the IOP measure-
ment time points vary widely. Other issues that have
not been addressed in relation to the WDT is the
possible need for adjustment factors depending on
the patient’s body weight or prior hydration status.
Finally, results of the WDT in medically treated
patients may be influenced by when the provocation
is performed in relation to the time-dependent
hypotensive effects (peak and trough efficacy) of
glaucoma medications.IV. Circadian Ocular Perfusion Pressure
Variation
Lowering of the IOP is the only evidence-based
treatment strategy that reduces the risk of de-
velopment and progression of OAG, but the disease
may progress despite adequately controlled IOP,
indicating that other factors are often implicated.
In particular, the role of vascular dysregulation and
the interplay of ocular perfusion pressure (OPP)
and blood flow may be important factors in
glaucoma.29,37,102
Blood flow in any organ is ensured by perfusion
pressure, that is, the difference between arterial BP
and venous BP (Fig. 3). Mean arterial blood
pressure (MAP) can be calculated as follows:MAP5DBPþ 1=3ðSBPDBPÞwhere DBP and SBP are the diastolic and systolic
blood pressures, respectively.
In the case of the eye, as IOP can be considered
equal to venous pressure, mean ocular perfusion
pressure (MOPP) is the difference between
ocular MAP and IOP.37 As the true MAP at the
level of a patient’s eye cannot be measured, MAP
at the approximate level of the heart from
routine brachial artery BP measurement has been
used to calculate ocular MAP. Non-human pri-
mate experiments have shown that MAP at the
level of the eye is approximately two-thirds of the
MAP determined at the level of the brachial
artery in the upright position.12,75 Hence, the
following equation is commonly used for the
calculation of MOPP from brachial artery MAP
values:12P52=3MAP  IOP5
2=3 ½DBPþ 1=3ðSBPDBPÞ  IOPOn the other hand, systolic (SOPP) and diastolic
(DOPP) ocular perfusion pressures are sometimes
calculated without taking into consideration the
difference of MAP at the level of the eye and the
level of the brachial artery:13SOPP5SBP IOPDOPP5DBP IOP
Some investigators have suggested MOPP be calcu-
lated according to the patient’s position (sitting or
supine), using the following equations:12,67,100MOPP ðsittingÞ5ð95=140MAPÞ  IOPMOPP ðsupineÞ5ð115=130MAPÞ  IOP
Regardless of the equations used in these calcula-
tions, the resultant values are only a surrogate for
the true OPP. Furthermore, there are inevitable
measurement inaccuracies during BP and IOP
assessment and the scales differ (IOP values are
typically in the 10--30 mm Hg range, but BP values
approximate 100 mm Hg). Despite these limita-
tions, several large studies have shown that calcu-
lated OPP is a highly relevant parameter in
glaucoma.
A. THE IMPORTANCE OF OPP IN OPEN-ANGLE
GLAUCOMA PREVALENCE, INCIDENCE, AND
PROGRESSION: EVIDENCE FROM LARGE TRIALS
The Baltimore Eye Survey included an equal
proportion of white and black participants and
indicated that individuals with DOPP lower than
30 mm Hg had a race- and age-adjusted risk of
POAG six times higher than individuals with DOPP
higher than 50 mmHg.116 In participants of African-
descent studied in the Barbados Eye Study, lower
DOPP was associated with higher prevalence of
OAG. Persons with DOPP values below the 20th
percentile were 3.3 times more likely to develop
glaucoma.60 A subsequent analysis indicated that
the 9-year relative risk of incident OAG with low
DOPP, low SOPP, and low MOPP was 2.1, 2.0, and
2.6, respectively.62 Similarly, the Egna-Neumarkt
study found a close relationship between OPP and
OAG in white participants: disease prevalence
increased at DOPP values less than 70 mm Hg,
although no relationship was detected with either
SOPP or MOPP.13 In the Proyecto VER study, the
prevalence of OAG in a Hispanic population was
found to increase four-fold with lower DOPP,96
Fig. 3. Hydrostatic column effect of postural position on blood pressure and ocular perfusion pressure. Adapted from
Caprioli and Coleman.16
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associated with OAG in white patients with IOP O
21 mm Hg who were treated for systemic hyperten-
sion.40 Data from the Singapore Malay Eye Study
showed that OAG risk is significantly higher in
ethnic Malay participants with DBP, MOPP, or DOPP
in the lowest quartile than in participants in the
highest quartile.127 Interestingly, the Beijing Eye
Study did not identify OPP as a risk factor for either
high- or low-pressure OAG.125 Possible reasons for
such a discrepancy may result from differences in
glaucoma definition, the fact that many patients
were untreated, the relatively large proportion of
patients with low IOP, and ethnic differences. The
Early Manifest Glaucoma Trial (EMGT), a prospec-
tive randomized study that evaluated risk factors for
progression in 255 white patients with OAG, in-
dicated that low SOPP was a predictor of
progression.61
Thus, population-based studies and the EMGT
show that low perfusion pressure is a risk factor for
glaucoma. Nonetheless, these data should be
interpreted with caution, because, with the excep-
tion of the EMGT,61 the Singapore Malay EyeStudy,127 and the incidence report of the Barbados
Eye Study,62 the other results were not adjusted for
glaucoma medication or systemic antihypertensive
treatment. Furthermore, the significance of low
perfusion pressure may be different in persons
treated for systemic hypertension. For example, in
the Rotterdam Study low DOPP was associated with
increased prevalence of glaucoma only in partici-
pants treated for hypertension.40 Additionally, in the
Thessaloniki Eye Study low MOPP was associated
with increased cupping and decreased rim area in
non-glaucoma patients with decreased diastolic
pressure if antihypertensive treatment were used.118
Finally, different equations have been used for the
calculation of ocular perfusion pressure. The
investigators who wrote the incidence report of the
Barbados Eye Study62 and the Thessaloniki Eye
Study118 calculated MOPP as (2/3 MAP -- IOP). On
the contrary, the authors of the EMGT61 and the
Beijing eye study125 calculated MOPP as (MAP --
IOP).
Because both parameters used in the calculation
of OPP (i.e., BP and IOP) exhibit a circadian
rhythm, OPP is bound to be affected around the
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the characteristics of 24-hour OPP in healthy
volunteers and glaucoma patients, and the potential
role of such variation in OAG.
B. CIRCADIAN OPP RHYTHM IN HEALTHY EYES
Liu et al examined diurnal and nocturnal levels
of posture-adjusted MOPP in 16 younger and 16
older healthy adults who were not using any
systemic anti-hypertensive medication.66 In habitual
body positions (i.e., sitting at day and supine at
night) they found that OPP peaked at night for
both younger and older volunteers. Both OPP and
the diurnal-to-nocturnal increase of OPP was larger
in the older group throughout the 24 hours. Kida
et al measured 24-hour OPP and blood flow of the
optic disc and macula in 15 younger and 15 older
healthy volunteers.47 None of the younger partic-
ipants were using systemic medication, but 12 of
the older volunteers were routinely using at least
one systemic medication and four of them were on
anti-hypertensive drugs. The authors used a scan-
ning laser Doppler flowmeter to record blood
volume, flow, and velocity in the sitting position.
Older participants had significant decreases in
ocular blood flow parameters at night, despite
the MOPP (calculated as 95/140  MAP -- IOP)
remaining constant throughout the 24-hour cycle.
In younger volunteers, there was no change in
ocular blood flow parameters despite the finding
that MOPP decreased significantly at night. They
concluded that aging may compromise the autor-
egulatory capacity normally present in healthy
younger individuals that ensures adequate ocular
blood flow in the face of perfusion pressure
reductions. Because all measurements in this study
were made in the sitting position, the effects of
habitual postural changes were not taken into
account.
C. CIRCADIAN OPP RHYTHM IN EYES WITH
GLAUCOMA
1. Circadian OPP and Diagnosis or Severity
of Glaucoma
Two studies by Quaranta et al have investigated
24-hour DOPP in newly diagnosed, untreated POAG
patients who were not receiving any systemic
medication.92,94 In both reports, the calculated
DOPP peaked in the evening (either 6 PM or
10 PM), and the DOPP trough was observed at
approximately 4 AM. In general, the DOPP curves
correlated with the systemic BP curves.
More recently, Costa et al20 examined the
circadian IOP, BP, SOPP, and DOPP profiles of
24 healthy adults and 29 washed-out POAGpatients with Goldmann tonometry during wake
hours (8 AM--10 PM) and Perkins tonometry
during sleep hours (12 AM--6 AM). None of the
participants were receiving any systemic vasoactive
medication. The authors found that both groups
tended to have higher IOP values at night. In
POAG patients, however, the nighttime IOP in-
crease was accompanied by a simultaneous de-
crease in DBP, resulting in the reduction of DOPP.
Interestingly, glaucoma patients had higher SBP
readings than controls at most time-points. As
a result, POAG patients had higher (8 AM and 10
AM) or similar SOPP values (12 PM--6 AM)
compared with controls.
Sehi et al investigated diurnal OPP profiles of 14
untreated glaucoma patients and 14 age-matched
healthy volunteers103 who were not receiving any
systemic vasoactive medication. They did not specif-
ically indicate if the same applied to the glaucoma
patients. Compared to the control group, the
glaucoma patients had higher IOP, lower MOPP
(calculated as 2/3MAP -- IOP), and wider MOPP
fluctuations. The minimum MOPP in the glaucoma
group was recorded at 7 AM, at the time when IOP
was at peak and BP at trough. This may suggest that
inadequate autoregulatory mechanisms in glaucoma
patients could prevent maintenance of adequate
blood flow in the face of nighttime changes in IOP
and BP.
In a study of 12 NTG patients and 12 controls not
using any systemic antihypertensive medication,
Okuno et al did not detect significant differences in
OPP when measurements were performed at 9 AM,
3 PM, and 9 PM.90 As nocturnal OPP was assessed
relatively early at 9 PM, nighttime changes in BP and
IOP may not have brought about changes in OPP.
In a retrospective analysis that included patients
on systemic antihypertensive medication, Choi et al
examined sitting IOP and BP over 24 hours in 132
untreated patients with NTG.18 Patients were classi-
fied into three groups based on the nocturnal MAP
reduction from their daytime levels: non-dippers
(!5% reduction), dippers (reduction $5% but
!10%), and over-dippers ($10% reduction). A
significant proportion of patients (41.7%) were
classified as over-dippers. There were no differences
among the groups in mean office IOP, IOP
fluctuation, mean 24-hour MOPP (calculated as 2/
3MAP-IOP), and glaucoma severity at diagnosis,
but over-dippers had significantly larger MOPP
fluctuations than the other groups. In a subsequent
report on 113 retrospectively reviewed NTG patients
that did not exclude participants on systemic
anti-hypertensive medication, Choi et al found that,
in a multivariate regression model, larger circadian
MOPP fluctuations were significantly associated with
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deviation, increased pattern standard deviation,
and increased Advanced Glaucoma Intervention
Study scores.19 Besides the association with func-
tional outcome variables, the model identified
MOPP fluctuation as an important predictor of
structural damage, such as a thinner retinal nerve
fiber layer. They suggested that MOPP fluctuations
may be a risk factor for NTG, as reductions of OPP
may lead to short-term ocular tissue ischemia,
followed by reperfusion injury and consequent loss
of retinal ganglion cells.2. Circadian OPP and Progression of Glaucoma
A number of investigations have found an
association between increased circadian MOPP
fluctuation and glaucoma progression. Sung et al
published a retrospective chart review of 101 NTG
patients with at least 4 years of follow-up and
24-hour sitting IOP and MOPP tracings.111 Multi-
variate regression analysis identified baseline pat-
tern standard deviation and 24-hour MOPP
fluctuations as significant predictors of visual field
progression. According to the model, each mm Hg
increase in MOPP fluctuation was associated with
approximately 27% greater hazard ratio of glau-
coma progression during follow-up. The same
authors subsequently published another report
identifying high diurnal MOPP fluctuation as the
most consistent predictive factor for central visual
field progression in treated NTG patients.112 In
their retrospective chart review of 101 eyes, patients
with high and low MOPP fluctuation had the same
risk of progression in the 10--24 degrees of the
visual field. The cumulative probability of visual
field progression within the central 10 degrees was
significantly higher for patients with higher MOPP
fluctuation, however. Multivariate regression analy-
sis found only 24-hour MOPP fluctuation to be
a predictor of central visual field progression. In
explaining their findings, the authors suggest that
the similarity of functional defects often observed
in NTG and non-arteritic ischemic optic neuropa-
thy, and the fact that these conditions have been
associated with BP decreases,36 both point towards
disturbances of retrobulbar hemodynamics as
important contributing factors.
In a prospective study, Renard et al100 used
a nonlinear least-squares dual-harmonic regression
analysis to examine 24-hour IOP, BP, and MOPP
curves in a group of 27 NTG patients that had
been appropriately washed-out of topical medica-
tions. They used two different equations for the
calculation of MOPP at the sitting and the supine
positions:MOPPðsittingÞ5ð95=140MAPÞ  IOPMOPPðsupineÞ5ð115=130MAPÞ  IOP
They found a diurnal IOP peak in 54% of patients
and a nocturnal peak in 36%, and no particular
rhythm in 9%. Similarly, 24-hour MOPP was
classified as either diurnal (58% of cases) or
nocturnal (42% of cases) according to the time of
the peak. The MOPP rhythm was closely related to
the 24-hour BP curve, rather than the IOP curve.
This implies that IOP changes hardly affect OPP
changes. As the authors point out, this can be
predicted by considering the relative weigh of BP
compared to IOP in the OPP equation. Moreover,
the amplitude of MOPP was not significantly
associated with glaucoma severity at inclusion.
D. THE EFFECT OF TOPICAL MEDICATIONS ON
OPP RHYTHM
By influencing IOP and possibly BP profiles,
medications used in the management of glaucoma
are likely to affect OPP profiles. Ideally, pharmaco-
logical agents should lower IOP without adversely
affecting OPP. Quaranta et al evaluated the effects
of most common anti-glaucoma drugs on 24-hour
DOPP92 in 27 newly diagnosed, untreated POAG
patients given timolol 0.5% twice daily, brimonidine
0.2% twice daily, dorzolamide 2% three times daily,
or latanoprost 0.005% in the evening. Diurnal
sitting IOP was measured with a Goldmann tonom-
eter and nocturnal supine IOP with a Tono-pen.
Compared with baseline, all medications decreased
the IOP significantly at all time points. Details of the
24-hour IOP results of this study were discussed in
a previous paragraph. Timolol and brimonidine
significantly lowered 24-hour mean BP; timolol
caused a fairly uniform, significant decrease in both
SBP and DBP at all time points, and brimonidine
lowered them mainly during night hours. Com-
pared with baseline, both dorzolamide and latano-
prost significantly increased DOPP at all time points.
The increase in mean circadian calculated DOPP
with timolol was not statistically significant; brimo-
nidine, however, significantly decreased mean 24-
hour DOPP. In general, both latanoprost and
dorzolamide had a statistically similar effect on
mean 24-hour DOPP in these naive POAG patients.
In another cross-over study, Quaranta et al94
investigated the effect of latanoprost and timolol-
dorzolamide fixed combination (TDFC) on 24-hour
IOP and DOPP in a group of 27 previously
untreated, newly diagnosed POAG patients. Both
TDFC and latanoprost significantly reduced mean
24-hour IOP, as well as IOP at individual time-points,
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24-hour cycle (1.3 mm Hg, p ! 0.001). Although
TDFC lowered both systolic and diastolic 24-hour BP
in a statistically significant way, DOPP was signifi-
cantly increased compared with baseline because of
the proportionally greater IOP reduction. Latano-
prost did not induce a BP reduction but its IOP-
lowering effect resulted in DOPP being increased.
The observed elevation of DOPP from baseline was
not significantly different for the two medications
neither for the 24-hour curve (5.9 mm Hg with
TDFC and 6.5 mm Hg with latanoprost, p 5 0.09)
nor for the night (5.7 mm Hg with either drug, p 5
0.970). The increase from baseline during the day
was marginally greater with latanoprost (6.8 mm Hg
vs 6.0 mm Hg, p 5 0.049).
In an open-label study, Ishibashi et al41 investi-
gated the effect of latanoprost 0.005% on circadian
sitting IOP and MOPP (calculated as 2/3MAP --
IOP) in 22 NTG patients. Latanoprost significantly
lowered mean 24-hour IOP, but did not affect BP
and MOPP. They suggest that the lack of MOPP
change could be attributed to the relatively small
IOP reduction (12.5%) observed with latanoprost in
this series of low-IOP patients (13.9 mm Hg at
baseline). Sample size and study design may also
account for these results, which were not confirmed
by a crossover, investigator-masked study95 on the
effect of latanoprost 0.005% and bimatoprost 0.03%
on 24-hour IOP and BP. In 40 newly diagnosed,
previously untreated NTG patients, both medica-
tions had a similar ocular hypotensive effect over the
mean 24-hour IOP (16% reduction from baseline)
and at each time point. Following treatment with
latanoprost, the circadian DOPP manifested a small
(3%), but significant, increase compared to baseline
(p 5 0.031). The increase of circadian DOPP was
not significant with bimatoprost (2%, p 5 0.21).
When treatments were compared directly, the DOPP
was similar in both groups for the 24-hour curve and
for all time-points.
In a crossover study of 60 eyes of 30 newly
diagnosed NTG patients, Costagliola et al21 in-
vestigated the influence of latanoprost 0.005% and
timolol 0.5% on 24-hour sitting IOP, BP, and MOPP
(calculated as 2/3MAP -- IOP). Although both
medications significantly reduced mean circadian
IOP compared to baseline, there was a difference of
1.3 mm Hg in favor of latanoprost. Both 24-hour
SBP and DBP were significantly reduced after
treatment with timolol, but were not changed after
treatment with latanoprost. Although latanoprost
significantly raised 24-hour MOPP, timolol did not
affect it. Compared with the reports previously
mentioned, mean IOP at baseline was higher than
in other studies with NTG patients (18.4  2.3 mmHg) and single IOP measurements reached 27 mm
Hg, with eight individual readings $ 24 mm Hg.V. Conclusion
The currently available literature on the circadian
IOP cycle fails to answer important questions about
the optimal way of characterizing IOP fluctuation
and the significance of such changes in glaucoma
management. Although adequately powered, pro-
spective trials are not available, the data from
smaller studies suggest that high 24-hour fluctuation
may have detrimental effects in eyes with glaucoma.
As 24-hour IOP measurements are impractical for
the majority of patients and clinicians, the identifi-
cation of appropriate surrogate measures of circa-
dian fluctuation is important. The currently
emerging continuous IOP monitoring technolo-
gies22,44,78 may soon offer important contributions
to the study of IOP rhythms. Once telemetric
technologies become validated and widely available
for clinical use, they may provide an invaluable tool
towards a better understanding of long- and short-
term IOP fluctuations during a patient’s undis-
turbed daily routine. Some of the obvious benefits
for research and clinical purposes include the
elucidation of IOP and OPP rhythms in healthy
and glaucomatous eyes, the response to medication,
or the evaluation of IOP characteristics as predictors
of disease progression.
A significant body of literature has highlighted the
importance of 24-hour OPP in patients with glau-
coma. Nonetheless, the precise relevance of these
findings for clinical practice is not always clear. One
of the problems with the application of such results to
individual patients is related to the fact that the actual
validity of calculated OPP measurements is limited.
For example, brachial artery pressure is used, with or
without correction, instead of ophthalmic or central
retinal artery pressure. Additionally, a consensus on
the equation that should be used to calculate theOPP
in the supine position has yet to be reached. In fact,
when the data set of a study by Costa et al20 was
analyzed with postured-adjusted OPP formulas,
rather than the commonly used single-posture
formula, an increase, rather than a decrease, in
night-time DOPP was found for POAG patients.76
Despite the fact that calculated OPP has proved to be
a valuable surrogate of actual OPP, sources of error
may still be introduced because the validation of
blood perfusion and flow models at the level of the
eye is practically unattainable. Additionally, the
significance of perfusion pressure across the IOP
spectrum may vary. For instance, low DOPP in the
Rotterdam Study was associated positively with OAG
in patients with IOPO 21mmHg treated for systemic
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patients.40 As discussed previously, 24-hour BP
measurements (and hence OPP values) performed
in a hospital setting may not closely reflect a patient’s
usual daily rhythm.91
Although the relevance of OPP characteristics as
risk factors in glaucoma has been highlighted by
several studies, an important question that remains
is whether increasing the OPP in glaucoma
patients would actually be beneficial. Although
such a course of action seems biologically plausi-
ble, evidence concerning the potential effects of
such a strategy is currently lacking. In addition,
ophthalmologists need to be aware that although
nocturnal hypotension (‘‘dipping’’) has been
associated with glaucoma progression, its existence
offers significant protection against cardiovascular
mortality. For example, ‘‘non-dippers’’ have a 20%
increased risk of death from stroke, heart attack,
or heart failure.27,28,89 Based on the notion that
low BP can be detrimental for some glaucoma
patients, increasing salt intake might appear
appealing, but increasing BP is associated with
a higher risk of cardiovascular morbidity. Addi-
tionally, caution is needed when systemic medica-
tions that have been shown to exert beneficial
vasoregulatory effects in experimental settings are
used in clinical practice. For example, although
systemic calcium channel blockers may enhance
ocular blood flow,59 there was an increased in-
cidence of glaucoma in patients receiving these
medications in the Rotterdam Eye Study.86
Despite the recognition of circadian IOP and OPP
as important factors in OAG, future research will
need to address a number of issues. Because
glaucoma represents a heterogeneous group of
related optic neuropathies, there may be subgroups
of patients in whom vascular factors are important.
Consequently, an important direction for future
research would be to identify and better characterize
these subgroups so that more appropriate treatment
strategies are used. Additionally, it will be important
to quantify the potential changes in ocular bloodflow
resulting from changes in OPP. On the other hand, it
has been shown that OPP and its circadian rhythm is
influenced by the BP and the IOP rhythms. However,
the influence of BP on intracranial pressure and its
fluctuation, and the potential significance of such
changes on the translaminar pressure, remains to be
determined. This issue is further complicated by the
effects of systemic and topical medication on IOP, BP,
and intracranial pressure.
Although more research is needed to refine our
current understanding of the role of perfusion
pressure and its circadian fluctuation in glaucoma, anappreciable body of evidence indicates that the in-
troduction of OPP evaluation in clinical management
may be valuable in a significant number of patients.VI. Method of Literature Search
The Medline database was used for the literature
search of this review. Although every effort was made
to use the most recent references possible, articles
irrespective of the year of publication were used if
deemed appropriate. The key words searched in-
cluded: intraocular pressure, ocular perfusion pressure,
glaucoma, circadian fluctuation, diurnal rhythm, risk
factors. Combinations of these terms with appropri-
ate boolean operators were also used. After
retrieving relevant articles using these key words,
a search was conducted through the literature cited
in these articles and additional papers were identi-
fied. Abstracts of papers in languages other than
English were surveyed, too. Medical Subject Head-
ings (MeSH) searches were also performed. Case
reports and abstracts from meeting presentations
were not used.VII. Disclosure
The authors report no proprietary or commercial
interest in any product mentioned or concept
discussed in this article.References
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